Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Joan Carlos Reverter"'
Autor:
Daniel Franz Lozano Beltran, Sandro Villarroel, Cristina Alonso-Vega, Nair Montano, Jimena Ramos Morales, Alejandro Palacios Lopez, Juan Carlos Ramirez, Tomás Duffy, Margarita Bisio, Alejandro G. Schijman, Lourdes Ortiz, Roxana Challapa Quechover, Silvia Sanz Sender, Paul Matthias Diderichsen, Eugene Cox, Nilce Mendoza, Michel Vaillant, Faustino Torrico, Fabiana Alves, Lineth Garcia, Igor C. Almeida, Gimena Rojas Delgadillo, Lizeth Rojas Panozo, Michael Everson, Maria Yurly Escobar Caballero, Fred Duncanson, Rudy Nelson Vasco Arenas, Isabel Gonzales, Helmut Ramon Magne Anzoleaga, Makoto Asada, Wladimiro Jimenez, Facundo Garcia-Bournisen, David Wesche, Carlos Florencio Hoyos Delfin, Letty Cardozo, Luis Izquierdo, Isabela Ribeiro, Erika Correia, Bethania Blum, Nathalie Strub-Wourgaft, María-Jesús Pinazo, Glaucia Santina, Manuel Morales, Albert Mendoza Zalabar, Joaquim Gascon, Rudy Parrado, Alexandre F. Marques, Antonia Daniels, Joan Carlos Reverter, Jimy Jose Pinto Rocha, Violeta Alejandra Fernandez Galvez, Anabelle de la Barra, Dunia Torrico Terceros, Gabriela Cuellar
Publikováno v:
The Lancet Infectious Diseases. 18:419-430
Background: Chagas disease is a major neglected vector-borne disease. In this study, we investigated the safety and efficacy of three oral E1224 (a water-soluble ravuconazole prodrug) regimens and benznidazole versus placebo in adult chronic indeterm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148eb68d473064a3db9cd188eff30caa
https://doi.org/10.1016/s1473-3099(17)30538-8
https://doi.org/10.1016/s1473-3099(17)30538-8
